Aesthetic medicine has long undergone a conceptual transition that increasingly aligns it with regenerative medicine. The goal is no longer merely to restore lost volume or neutralize a wrinkle with a paralytic agent, but rather to induce a biological response within the skin capable of reorganizing the extracellular matrix, reactivating quiescent cell populations, and rebuilding a dermal microenvironment that is functionally more youthful. It is within this space—midway between cosmetics and therapeutics—that bioactive biomaterials have found a distinct role. Among these, fibroin in particular, but also sericin, long regarded as a waste by-product, have emerged as valuable tools for skin rejuvenation strategies because they combine documented biocompatibility, tunable biodegradability, and an intrinsic capacity to interact with dermal biology.
Why fibroin matters for skin regeneration
Fibroin is the structural component of silk, a fibrous protein composed of a heavy chain of approximately 390 kDa and a light chain of approximately 26 kDa, linked by a disulfide bond and associated with the glycoprotein P25. Its functional identity lies in the alternation between crystalline domains, formed by repetitive glycine-alanine motifs arranged into antiparallel β-sheets, and amorphous regions that confer elasticity.
This architecture is not merely an academic detail; it is precisely what makes fibroin highly engineerable. By modulating the transition from the amorphous conformation known as Silk I to the crystalline β-sheet conformation known as Silk II, it becomes possible to control aqueous stability, mechanical strength, and—most importantly for regenerative applications—the kinetics of proteolytic degradation.
For aesthetic medicine, this controllability distinguishes fibroin from many other scaffolds. A support that degrades too rapidly does not allow sufficient time for cells to remodel tissue, whereas one that persists excessively may behave as a chronic foreign body. Fibroin allows the design of a residence time consistent with the timeline of neocollagenesis, serving as a temporary scaffold while the dermis rebuilds its matrix and subsequently being resorbed without significant residues. This is complemented by a favorable immunological profile, low inflammatory response, and a well-established regulatory history, as silk-derived materials have been used in implantable medical devices for decades.
Dialogue with fibroblasts and keratinocytes
The effectiveness of a regenerative biomaterial is measured not by its physical properties but by the cellular response it elicits. Although fibroin does not naturally possess a high density of RGD-type adhesion sequences, it provides a surface that reliably supports the adhesion, migration, and proliferation of dermal fibroblasts and keratinocytes.
Evidence accumulated in the field of wound healing—where fibroin membranes and hydrogels accelerate re-epithelialization and organize new granulation tissue—provides the biological foundation that regenerative aesthetic medicine applies to aged skin rather than injured skin.
The key cellular target is the fibroblast. In photoaged skin, fibroblasts lose mechanical tension, reduce the synthesis of type I and III collagen and elastin, and shift toward a catabolic phenotype characterized by overexpression of matrix metalloproteinases. A fibroin scaffold that recreates a three-dimensional architecture offers fibroblasts a substrate for attachment, a mechanotransductive signal capable of reactivating their synthetic function, and a geometry that reorganizes the deposition of new extracellular matrix.
Several studies have also documented fibroin's ability to attenuate oxidative stress and modulate inflammatory pathways, two central factors in the pathophysiology of skin aging. The result is not passive filling but active stimulation of dermal remodeling, conceptually similar to what is expected from a biostimulatory agent.
Formats that deliver fibroin into the dermis
One of fibroin's most underestimated advantages is its formulation versatility. The same protein can be processed into injectable hydrogels, thin films, porous sponges, microneedles, nanoparticles, and nanofibrous membranes, each addressing different aesthetic applications.
Fibroin hydrogels, obtained through physical gelation induced by sonication, pH reduction, or enzymatic crosslinking using peroxidases, are perhaps the most promising platform for injection. A hydrogel that gels in situ can act as a biostimulatory volumizer, restoring tissue fullness while inducing endogenous matrix synthesis, with a resorption profile that can be tuned through the degree of protein crystallinity. In this context, fibroin may serve as a complementary or alternative option to traditional stimulatory fillers, offering physiological enzymatic degradation and remarkable rheological flexibility.
Dissolving fibroin microneedles represent another important application in painless transdermal delivery. Microneedles composed entirely of fibroin, or fibroin loaded with active ingredients, penetrate the stratum corneum without stimulating nerve endings and release peptides, antioxidants, retinoids, or growth factors directly into the dermis, overcoming the barrier that limits the effectiveness of conventional topical applications. Fibroin protects labile molecules during storage and modulates their release as the matrix dissolves.
Fibroin nanoparticles and microspheres perform a similar function at a different scale, encapsulating both hydrophilic and hydrophobic cosmeceutical actives—from vitamin C and resveratrol to epigallocatechin gallate and retinoids—protecting them from oxidation and degradation until targeted release.
Electrospun films and membranes, meanwhile, recreate a topography that mimics the fibrillar architecture of the extracellular matrix, providing fibroblasts with spatial guidance that promotes more organized collagen deposition. Used as masks or bioactive dressings, they can deliver active ingredients while maintaining an occlusive and hydrated microenvironment.
The mechanism of regeneration: beyond filling
It is important to emphasize what distinguishes a regenerative approach from a purely corrective one, because this is where fibroin demonstrates its added value.
A conventional hyaluronic acid filler acts primarily through volumization and water retention, producing an effect that is reversible and dependent on the persistence of the gel. A fibroin scaffold, by contrast, can trigger a process of neocollagenesis that continues to provide benefits even after the material has been resorbed, because what remains is not the scaffold itself but the tissue that the skin has built around and within it.
This logic brings fibroin close to the paradigm of biostimulators, but with a qualitative distinction. Whereas conventional biostimulators often rely on a controlled foreign-body response, fibroin acts predominantly through biomimicry, providing a substrate that cells recognize as compatible with the extracellular matrix and that integrates rather than opposes natural reparative processes.
The combination with controlled-release systems further amplifies this effect. Loading the scaffold with growth factors, exosomes, or platelet-rich plasma superimposes biochemical stimulation onto mechanical stimulation, creating a temporary regenerative niche within the dermis.
Sericin deserves a place in the discussion
The question of sericin warrants a clear answer: not only can it be included, but omitting it from an article on regenerative aesthetics would leave a significant gap.
Sericin is the adhesive protein that coats fibroin filaments within the silk cocoon. Traditionally removed during the degumming process and long considered a by-product of silk manufacturing, sericin's reputation has been transformed by research demonstrating its value as both a cosmetic and biomedical active ingredient—arguably one more directly suited to skin applications than fibroin itself.
Its amino acid composition explains many of its properties. Sericin is particularly rich in serine and contains substantial amounts of aspartic acid and threonine, residues with hydroxyl groups that confer remarkable hygroscopic capacity. This underlies its moisturizing and film-forming effects, which improve barrier function and stratum corneum cohesion.
Sericin also exhibits documented antioxidant activity, scavenging reactive oxygen species and reducing lipid peroxidation. Of particular interest is its ability to inhibit tyrosinase, resulting in skin-brightening effects and modulation of melanogenesis that may be useful in managing photoaging-related dyschromia.
Several studies further report stimulation of fibroblast proliferation and collagen synthesis, as well as anti-elastase activity that contributes to preserving elastic fibers, completing a profile that is effectively anti-aging.
Regarding biocompatibility, it is important to clarify a historical misconception. Early concerns about sericin immunogenicity largely stemmed from poorly purified preparations contaminated with fibroin residues. Purified sericin demonstrates a favorable safety profile.
This reappraisal has paved the way for composite systems in which sericin and fibroin work synergistically: sericin contributes hydration, antioxidant protection, and bioactive signaling, while fibroin provides mechanical structure and controlled degradation. Sericin-fibroin hydrogels and scaffolds, as well as sericin coatings or bioactive phases within fibroin matrices, likely represent one of the most promising directions, as they capitalize on the complementary nature of the two proteins rather than treating them as alternatives.
Functionalization and combination strategies
The maturity of a biomaterial is also measured by its capacity to serve as a platform for other molecules, and fibroin offers considerable potential in this regard. Reactive groups along the protein chain allow conjugation with adhesion peptides, incorporation of growth factors such as EGF and FGF-2, anchoring of bioactive sequences, and fine modulation of surface charge.
In blended systems, fibroin combines effectively with hyaluronic acid to unite hydration and structural support, with collagen and elastin to reconstruct a more complete dermal microenvironment, and with sericin for the reasons already discussed. Crosslinking is not merely a means of achieving stability. By regulating crosslink density and bond type, it is possible to control the release rate of encapsulated actives and the duration of biostimulation, enabling treatment customization according to individual patient biology and specific indications.
This programmability reflects fibroin's strong potential for personalization, an increasingly important theme in contemporary aesthetic medicine, where the goal is no longer a standardized effect but a response tailored to the unique biology of each patient's skin.
Regulatory and translational challenges
Any serious discussion of biomaterials intended for skin applications must consider the regulatory dimension, particularly because silk proteins occupy a blurred boundary between cosmetics, medical devices, and biologically active products.
Classification depends on the intended claims, route of administration, and declared mechanism of action. A sericin-based topical serum follows a very different regulatory pathway from an injectable fibroin hydrogel designed for biostimulation, and substantiating product claims requires evidence appropriate to the relevant regulatory framework. Translational challenges remain significant. Standardization of preparations, reproducibility of molecular weight and crystallinity, sterilization without compromising bioactivity, and control of raw material variability are all factors that separate a laboratory concept from a reliable commercial product.
It is precisely in this transition—from scientific observation to robust evidence and defensible claims—that the true value of fibroin will ultimately be determined, and where rigorous scientific validation becomes an integral part of both the clinical and commercial proposition.
A direction rather than a trend
What makes silk proteins attractive for skin rejuvenation is not novelty itself, but the convergence of biomimicry, programmability, and sustainability.
Fibroin provides a scaffold that the dermis can recognize and remodel; sericin contributes a range of activities directly beneficial to skin health. Together they form a natural, biodegradable, low-impact protein platform that aligns with the growing demand for solutions that are both effective and environmentally responsible. The most likely future is not one in which these proteins compete with existing technologies, but one in which they function as connective elements within integrated therapeutic strategies, where structural support, controlled delivery of active ingredients, and biological signaling work together to restore the skin toward a more youthful functional equilibrium.
For professionals involved in scientific communication and validation within this field, the challenge is to present this promise with the precision it deserves, clearly distinguishing what current evidence already supports from what remains, for now, a promising avenue for future research.
